Novartis AG
SWB:NOT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Novartis AG
SWB:NOT
|
CH |
|
C
|
Celestica Inc
XMUN:CTW
|
CA |
|
C
|
China Water Affairs Group Ltd
XBER:CUBB
|
HK |
|
C
|
Coty Inc
F:CO3A
|
US |
|
Creative Technology Ltd
F:CTL
|
SG |
|
A
|
AZZ Inc
F:AI7
|
US |
|
P
|
Pilgrims Pride Corp
XBER:6PP
|
US |
|
AC Immune SA
F:IMR
|
CH |
|
M
|
Memscap SA
F:MSBA
|
FR |
|
I
|
Insulet Corp
SWB:GOV
|
US |
|
Yara International ASA
OSE:YAR
|
NO |
|
P
|
Papa John's International Inc
F:PP1
|
US |
|
V
|
Vinci SA
XBER:SQU
|
FR |
|
Silverlake Axis Ltd (Pre Reincorporation)
SGX:5CP
|
MY |
|
LPKF Laser & Electronics AG
F:LPK
|
DE |
Wall St Price Targets
NOT Price Targets Summary
Novartis AG
According to Wall Street analysts, the average 1-year price target for NOT is 135.09 EUR with a low forecast of 99.79 EUR and a high forecast of 159.6 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NOT's stock price target?
Price Target
135.09
EUR
According to Wall Street analysts, the average 1-year price target for NOT is 135.09 EUR with a low forecast of 99.79 EUR and a high forecast of 159.6 EUR.
What is the Revenue forecast for Novartis AG?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 8 years is 2%.
What is the Operating Income forecast for Novartis AG?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 8 years is 6%.
What is the Net Income forecast for Novartis AG?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Net Income has been 3%. The projected CAGR for the next 8 years is 7%.
